These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | ||||
For the Quarterly Period Ended September 30, 2024 |
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
|
|
|
||||||||||||||||||||||
(State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) | ||||||||||||||||||||||
|
|
|
|
|
|||||||||||||||||||
(Address of principal executive offices) |
Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||
|
|
|
|
☑ | Accelerated filer | ☐ | Non-accelerated filer | ☐ |
Smaller reporting
company |
|
Emerging growth
company |
|
||||||||||||||||||||
Page | ||||||||
PART I FINANCIAL INFORMATION | ||||||||
ITEM 1. | ||||||||
ITEM 2. | ||||||||
ITEM 3. | ||||||||
ITEM 4. | ||||||||
PART II OTHER INFORMATION | ||||||||
ITEM 1. | ||||||||
ITEM 1A. | ||||||||
ITEM 2. | ||||||||
ITEM 5. | ||||||||
ITEM 6. | ||||||||
Three months ended | Nine months ended | ||||||||||||||||
In millions, except per-share data |
September 30,
2024 |
September 30,
2023 |
September 30,
2024 |
September 30,
2023 |
|||||||||||||
Net sales | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||
Cost of goods sold |
|
|
|
|
|||||||||||||
Gross profit |
|
|
|
|
|||||||||||||
Selling, general and administrative expenses |
|
|
|
|
|||||||||||||
Research and development expenses |
|
|
|
|
|||||||||||||
Operating income |
|
|
|
|
|||||||||||||
Other expense (income)
|
|||||||||||||||||
Net interest expense |
|
|
|
|
|||||||||||||
Other (income) expense
|
(
|
(
|
|
(
|
|||||||||||||
Income from continuing operations before income taxes |
|
|
|
|
|||||||||||||
Provision for income taxes |
|
|
|
|
|||||||||||||
Net income from continuing operations |
|
|
|
|
|||||||||||||
Loss from discontinued operations, net of tax
|
|
|
(
|
(
|
|||||||||||||
Net income | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||
Comprehensive income, net of tax | |||||||||||||||||
Net income | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||
Changes in cumulative translation adjustment |
|
(
|
|
(
|
|||||||||||||
Changes in market value of derivative financial instruments, net of tax |
(
|
|
(
|
|
|||||||||||||
Comprehensive income | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||
Earnings per ordinary share
|
|||||||||||||||||
Basic | |||||||||||||||||
Continuing operations | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||
Discontinued operations |
|
|
|
|
|||||||||||||
Basic earnings per ordinary share | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||
Diluted | |||||||||||||||||
Continuing operations | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||
Discontinued operations |
|
|
|
|
|||||||||||||
Diluted earnings per ordinary share | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||
Weighted average ordinary shares outstanding | |||||||||||||||||
Basic |
|
|
|
|
|||||||||||||
Diluted |
|
|
|
|
|||||||||||||
September 30,
2024 |
December 31,
2023 |
|||||||
In millions, except per-share data | ||||||||
Assets | ||||||||
Current assets | ||||||||
Cash and cash equivalents | $ |
|
$ |
|
||||
Accounts receivable, net of allowances of $
|
|
|
||||||
Inventories |
|
|
||||||
Other current assets |
|
|
||||||
Total current assets |
|
|
||||||
Property, plant and equipment, net |
|
|
||||||
Other assets | ||||||||
Goodwill |
|
|
||||||
Intangibles, net |
|
|
||||||
Other non-current assets |
|
|
||||||
Total other assets |
|
|
||||||
Total assets | $ |
|
$ |
|
||||
Liabilities and Equity | ||||||||
Current liabilities | ||||||||
Accounts payable | $ |
|
$ |
|
||||
Employee compensation and benefits |
|
|
||||||
Other current liabilities |
|
|
||||||
Total current liabilities |
|
|
||||||
Other liabilities | ||||||||
Long-term debt |
|
|
||||||
Pension and other post-retirement compensation and benefits |
|
|
||||||
Deferred tax liabilities |
|
|
||||||
Other non-current liabilities |
|
|
||||||
Total liabilities |
|
|
||||||
Commitments and contingencies (Note 15)
|
||||||||
Equity | ||||||||
Ordinary shares $
|
|
|
||||||
Additional paid-in capital |
|
|
||||||
Retained earnings |
|
|
||||||
Accumulated other comprehensive loss |
(
|
(
|
||||||
Total equity |
|
|
||||||
Total liabilities and equity | $ |
|
$ |
|
Nine months ended | ||||||||
In millions |
September 30,
2024 |
September 30,
2023 |
||||||
Operating activities | ||||||||
Net income | $ |
|
$ |
|
||||
Loss from discontinued operations, net of tax
|
|
|
||||||
Adjustments to reconcile net income from continuing operations to net cash provided by (used for) operating activities | ||||||||
Equity income of unconsolidated subsidiaries |
(
|
(
|
||||||
Depreciation |
|
|
||||||
Amortization |
|
|
||||||
Deferred income taxes |
|
(
|
||||||
Share-based compensation |
|
|
||||||
Asset impairment and write-offs |
|
|
||||||
Gain on sale of assets |
|
(
|
||||||
Changes in assets and liabilities, net of effects of business acquisitions | ||||||||
Accounts receivable |
|
|
||||||
Inventories |
|
|
||||||
Other current assets |
|
(
|
||||||
Accounts payable |
|
(
|
||||||
Employee compensation and benefits |
(
|
|
||||||
Other current liabilities |
(
|
(
|
||||||
Other non-current assets and liabilities |
|
|
||||||
Net cash provided by operating activities of continuing operations
|
|
|
||||||
Net cash used for operating activities of discontinued operations |
(
|
(
|
||||||
Net cash provided by operating activities
|
|
|
||||||
Investing activities | ||||||||
Capital expenditures |
(
|
(
|
||||||
Proceeds from sale of property and equipment |
|
|
||||||
Payments upon the settlement of net investment hedges
|
(
|
|
||||||
Acquisitions, net of cash acquired |
|
(
|
||||||
Other |
(
|
|
||||||
Net cash used for investing activities |
(
|
(
|
||||||
Financing activities | ||||||||
Net repayments of revolving long-term debt
|
|
(
|
||||||
Repayments of long-term debt |
(
|
(
|
||||||
Shares issued to employees, net of shares withheld |
|
|
||||||
Repurchases of ordinary shares |
(
|
|
||||||
Dividends paid |
(
|
(
|
||||||
Net cash used for financing activities
|
(
|
(
|
||||||
Effect of exchange rate changes on cash and cash equivalents |
(
|
(
|
||||||
Change in cash and cash equivalents |
|
|
||||||
Cash and cash equivalents, beginning of period |
|
|
||||||
Cash and cash equivalents, end of period | $ |
|
$ |
|
In millions | Ordinary shares | Additional paid-in capital | Retained earnings |
Accumulated
other
comprehensive (loss) income
|
Total | ||||||||||||||||||||||||||||||
Number | Amount | ||||||||||||||||||||||||||||||||||
Balance - December 31, 2023 |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
$ |
|
||||||||||||||||||||||||
Net income | — | — | — |
|
— |
|
|||||||||||||||||||||||||||||
Other comprehensive income, net of tax | — | — | — | — |
|
|
|||||||||||||||||||||||||||||
Dividends declared, $
|
— | — | — |
(
|
— |
(
|
|||||||||||||||||||||||||||||
Exercise of options, net of shares tendered for payment |
|
— |
|
— | — |
|
|||||||||||||||||||||||||||||
Issuance of restricted shares, net of cancellations |
|
— |
(
|
— | — |
(
|
|||||||||||||||||||||||||||||
Shares surrendered by employees to pay taxes |
(
|
— |
(
|
— | — |
(
|
|||||||||||||||||||||||||||||
Share-based compensation | — | — |
|
— | — |
|
|||||||||||||||||||||||||||||
Balance - March 31, 2024 |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
$ |
|
||||||||||||||||||||||||
Net income | — | — | — |
|
— |
|
|||||||||||||||||||||||||||||
Other comprehensive loss, net of tax | — | — | — | — |
(
|
(
|
|||||||||||||||||||||||||||||
Dividends declared, $
|
— | — | — |
(
|
— |
(
|
|||||||||||||||||||||||||||||
Share repurchases |
(
|
— |
(
|
— | — |
(
|
|||||||||||||||||||||||||||||
Exercise of options, net of shares tendered for payment |
|
— |
|
— | — |
|
|||||||||||||||||||||||||||||
Shares surrendered by employees to pay taxes | — | — |
(
|
— | — |
(
|
|||||||||||||||||||||||||||||
Share-based compensation | — | — |
|
— | — |
|
|||||||||||||||||||||||||||||
Balance - June 30, 2024
|
|
$ |
|
$ |
|
$ |
|
$ |
(
|
$ |
|
||||||||||||||||||||||||
Net income | — | — | — |
|
— |
|
|||||||||||||||||||||||||||||
Other comprehensive loss, net of tax | — | — | — | — |
(
|
(
|
|||||||||||||||||||||||||||||
Dividends declared, $
|
— | — | — |
(
|
— |
(
|
|||||||||||||||||||||||||||||
Share repurchase |
(
|
— |
(
|
— | — |
(
|
|||||||||||||||||||||||||||||
Exercise of options, net of shares tendered for payment |
|
— |
|
— | — |
|
|||||||||||||||||||||||||||||
Shares surrendered by employees to pay taxes | — | — |
(
|
— | — |
(
|
|||||||||||||||||||||||||||||
Share-based compensation | — | — |
|
— | — |
|
|||||||||||||||||||||||||||||
Balance - September 30, 2024 |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
$ |
|
In millions | Ordinary shares | Additional paid-in capital | Retained earnings |
Accumulated
other
comprehensive (loss) income
|
Total | ||||||||||||||||||
Number | Amount | ||||||||||||||||||||||
Balance - December 31, 2022 |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
$ |
|
||||||||||||
Net income | — | — | — |
|
— |
|
|||||||||||||||||
Other comprehensive income, net of tax
|
— | — | — | — |
|
|
|||||||||||||||||
Dividends declared, $
|
— | — | — |
(
|
— |
(
|
|||||||||||||||||
Exercise of options, net of shares tendered for payment |
|
— |
|
— | — |
|
|||||||||||||||||
Issuance of restricted shares, net of cancellations |
|
— |
(
|
— | — |
(
|
|||||||||||||||||
Shares surrendered by employees to pay taxes |
(
|
— |
(
|
— | — |
(
|
|||||||||||||||||
Share-based compensation | — | — |
|
— | — |
|
|||||||||||||||||
Balance - March 31, 2023 |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
$ |
|
||||||||||||
Net income | — | — | — |
|
— |
|
|||||||||||||||||
Other comprehensive loss, net of tax | — | — | — | — |
(
|
(
|
|||||||||||||||||
Dividends declared, $
|
— | — | — |
(
|
— |
(
|
|||||||||||||||||
Exercise of options, net of shares tendered for payment |
|
— |
|
— | — |
|
|||||||||||||||||
Shares surrendered by employees to pay taxes | — | — |
(
|
— | — |
(
|
|||||||||||||||||
Share-based compensation | — | — |
|
— | — |
|
|||||||||||||||||
Balance - June 30, 2023
|
|
$ |
|
$ |
|
$ |
|
$ |
(
|
$ |
|
||||||||||||
Net income | — | — | — |
|
— |
|
|||||||||||||||||
Other comprehensive loss, net of tax | — | — | — | — |
(
|
(
|
|||||||||||||||||
Dividends declared, $
|
— | — | — |
(
|
— |
(
|
|||||||||||||||||
Exercise of options, net of shares tendered for payment | 0.2 | — |
|
— | — |
|
|||||||||||||||||
Shares surrendered by employees to pay taxes | — | — |
(
|
— | — |
(
|
|||||||||||||||||
Share-based compensation | — | — |
|
— | — |
|
|||||||||||||||||
Balance - September 30, 2023 |
|
$ |
|
$ |
|
$ |
|
$ |
(
|
$ |
|
Three months ended | Nine months ended | ||||||||||||||||
In millions |
September 30,
2024 |
September 30,
2023 |
September 30,
2024 |
September 30,
2023 |
|||||||||||||
U.S. | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||
Western Europe |
|
|
|
|
|||||||||||||
Developing
(1)
|
|
|
|
|
|||||||||||||
Other Developed
(2)
|
|
|
|
|
|||||||||||||
Consolidated net sales | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||
(1)
Developing includes China, Eastern Europe, Latin America, the Middle East and Southeast Asia.
|
|||||||||||||||||
(2)
Other Developed includes Australia, Canada and Japan.
|
Three months ended | Nine months ended | ||||||||||||||||
In millions |
September 30,
2024 |
September 30,
2023 |
September 30,
2024 |
September 30,
2023 |
|||||||||||||
Residential | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||
Commercial |
|
|
|
|
|||||||||||||
Industrial |
|
|
|
|
|||||||||||||
Consolidated net sales | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||
In millions |
September 30,
2024 |
December 31,
2023 |
$ Change | % Change | |||||||||||||
Contract assets | $ |
|
$ |
|
$ |
(
|
(
|
% | |||||||||
Contract liabilities |
|
|
(
|
(
|
% | ||||||||||||
Net contract assets
|
$ |
|
$ |
|
$ |
(
|
(
|
% |
Three months ended | Nine months ended | ||||||||||||||||
In millions |
September 30,
2024 |
September 30,
2023 |
September 30,
2024 |
September 30,
2023 |
|||||||||||||
Restricted stock units | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||
Stock options |
|
|
|
|
|||||||||||||
Performance share units |
|
|
|
|
|||||||||||||
Total share-based compensation expense | $ |
|
$ |
|
$ |
|
$ |
|
2024
Annual Grant |
|||||
Risk-free interest rate |
|
% | |||
Expected dividend yield |
|
% | |||
Expected share price volatility |
|
% | |||
Expected term (years) |
|
Three months ended | Nine months ended | ||||||||||||||||
In millions |
September 30,
2024 |
September 30,
2023 |
September 30,
2024 |
September 30,
2023 |
|||||||||||||
Restructuring Initiatives | |||||||||||||||||
Severance and related costs | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||
Other restructuring costs and related adjustments
(1)
|
|
|
|
|
|||||||||||||
Total restructuring costs |
|
|
|
|
|||||||||||||
Transformation Program | |||||||||||||||||
Severance and related costs |
|
|
|
|
|||||||||||||
Other transformation costs
(2)
|
|
|
|
|
|||||||||||||
Total transformation costs |
|
|
|
|
|||||||||||||
Total restructuring and transformation costs | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||
(1)
Other restructuring costs and related adjustments primarily consist of certain accruals and related refinements as well as various contract termination costs, asset impairments and inventory write-offs associated with business and product line exits.
|
|||||||||||||||||
(2)
Other transformation costs primarily consist of professional services, project management related costs, asset impairments and inventory write-offs, partially offset by gain on sale of assets.
|
Three months ended | Nine months ended | ||||||||||||||||
In millions |
September 30,
2024 |
September 30,
2023 |
September 30,
2024 |
September 30,
2023 |
|||||||||||||
Flow | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||
Water Solutions |
|
|
|
|
|||||||||||||
Pool |
|
|
|
|
|||||||||||||
Corporate and other
|
|
|
|
|
|||||||||||||
Total restructuring and transformation costs
|
$ |
|
$ |
|
$ |
|
$ |
|
In millions |
September 30,
2024 |
||||
Beginning balance | $ |
|
|||
Costs incurred |
|
||||
Cash payments and other |
(
|
||||
Ending balance | $ |
|
Three months ended | Nine months ended | ||||||||||||||||
In millions, except per-share data |
September 30,
2024 |
September 30,
2023 |
September 30,
2024 |
September 30,
2023 |
|||||||||||||
Net income | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||
Net income from continuing operations
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||
Weighted average ordinary shares outstanding | |||||||||||||||||
Basic |
|
|
|
|
|||||||||||||
Dilutive impact of stock options, restricted stock units and performance share units
|
|
|
|
|
|||||||||||||
Diluted |
|
|
|
|
|||||||||||||
Earnings per ordinary share
|
|||||||||||||||||
Basic | |||||||||||||||||
Continuing operations | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||
Discontinued operations |
|
|
|
|
|||||||||||||
Basic earnings per ordinary share | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||
Diluted | |||||||||||||||||
Continuing operations | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||
Discontinued operations |
|
|
|
|
|||||||||||||
Diluted earnings per ordinary share | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||
Anti-dilutive stock options excluded from the calculation of diluted earnings per share
|
|
|
|
|
In millions |
September 30,
2024 |
|||||||
Beginning balance | $ |
|
||||||
Bad debt expense
|
(
|
|||||||
Write-offs, net of recoveries |
(
|
|||||||
Other
(1)
|
|
|||||||
Ending balance | $ |
|
||||||
(1)
Other amounts are primarily the effects of changes in currency translation and the impact of allowance for credits.
|
In millions |
September 30,
2024 |
December 31,
2023 |
||||||
Inventories | ||||||||
Raw materials and supplies | $ |
|
$ |
|
||||
Work-in-process |
|
|
||||||
Finished goods |
|
|
||||||
Total inventories | $ |
|
$ |
|
||||
Other current assets | ||||||||
Cost in excess of billings | $ |
|
$ |
|
||||
Prepaid expenses |
|
|
||||||
Other current assets |
|
|
||||||
Total other current assets | $ |
|
$ |
|
||||
Property, plant and equipment, net | ||||||||
Land and land improvements | $ |
|
$ |
|
||||
Buildings and leasehold improvements |
|
|
||||||
Machinery and equipment |
|
|
||||||
Capitalized software |
|
|
||||||
Construction in progress |
|
|
||||||
Total property, plant and equipment |
|
|
||||||
Accumulated depreciation and amortization |
|
|
||||||
Total property, plant and equipment, net | $ |
|
$ |
|
||||
Other non-current assets | ||||||||
Right-of-use lease assets | $ |
|
$ |
|
||||
Deferred income taxes |
|
|
||||||
Deferred compensation plan assets |
|
|
||||||
Other non-current assets |
|
|
||||||
Total other non-current assets | $ |
|
$ |
|
||||
Other current liabilities | ||||||||
Dividends payable | $ |
|
$ |
|
||||
Accrued warranty |
|
|
||||||
Accrued rebates and incentives |
|
|
||||||
Accrued freight |
|
|
||||||
Billings in excess of cost |
|
|
||||||
Current lease liability |
|
|
||||||
Income taxes payable |
|
|
||||||
Accrued restructuring |
|
|
||||||
Interest payable |
|
|
||||||
Other current liabilities |
|
|
||||||
Total other current liabilities | $ |
|
$ |
|
||||
Other non-current liabilities | ||||||||
Long-term lease liability | $ |
|
$ |
|
||||
Income taxes payable |
|
|
||||||
Self-insurance liabilities |
|
|
||||||
Deferred compensation plan liabilities |
|
|
||||||
Foreign currency contract liabilities |
|
|
||||||
Other non-current liabilities |
|
|
||||||
Total other non-current liabilities | $ |
|
$ |
|
In millions |
December 31,
2023 |
Foreign Currency
Translation |
September 30,
2024 |
||||||||||||||
Flow | $ |
|
$ |
|
$ |
|
|||||||||||
Water Solutions |
|
|
|
||||||||||||||
Pool |
|
|
|
||||||||||||||
Total goodwill | $ |
|
$ |
|
$ |
|
September 30, 2024 | December 31, 2023 | ||||||||||||||||||||||
In millions | Cost |
Accumulated
amortization |
Net | Cost |
Accumulated
amortization |
Net | |||||||||||||||||
Definite-life intangibles | |||||||||||||||||||||||
Customer relationships | $ |
|
$ |
(
|
$ |
|
$ |
|
$ |
(
|
$ |
|
|||||||||||
Proprietary technology and patents |
|
(
|
|
|
(
|
|
|||||||||||||||||
Total definite-life intangibles
|
|
(
|
|
|
(
|
|
|||||||||||||||||
Indefinite-life intangibles | |||||||||||||||||||||||
Trade names |
|
— |
|
|
— |
|
|||||||||||||||||
Total intangibles | $ |
|
$ |
(
|
$ |
|
$ |
|
$ |
(
|
$ |
|
Q4
|
||||||||||||||||||||
2024 | 2025 | 2026 | 2027 | 2028 | 2029 | |||||||||||||||
Estimated amortization expense | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
In millions | Average interest rate as of September 30, 2024 |
Maturity
Year |
September 30,
2024 |
December 31,
2023 |
||||||||||
Revolving credit facility (Senior Credit Facility) |
|
2026 | $ |
|
$ |
|
||||||||
Term Loan Facility |
|
2023 - 2027 |
|
|
||||||||||
Term loans (Senior Credit Facility) | N/A | 2024 |
|
|
||||||||||
Senior notes - fixed rate
(1)
|
|
2025 |
|
|
||||||||||
Senior notes - fixed rate
(1)
|
|
2029 |
|
|
||||||||||
Senior notes - fixed rate
(1)
|
|
2032 |
|
|
||||||||||
Unamortized debt issuance costs and discounts | N/A | N/A |
(
|
(
|
||||||||||
Total debt | $ |
|
$ |
|
||||||||||
(1)
Senior notes are guaranteed as to payment by Pentair plc.
|
Q4
|
|||||||||||||||||||||||||||||
In millions | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | Thereafter | Total | |||||||||||||||||||||
Contractual debt obligation maturities
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||
Level 1: | Valuation is based on observable inputs such as quoted market prices (unadjusted) for identical assets or liabilities in active markets. | |||||||
Level 2: | Valuation is based on inputs such as quoted market prices for similar assets or liabilities in active markets or other inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument. | |||||||
Level 3: | Valuation is based upon other unobservable inputs that are significant to the fair value measurement. |
September 30,
2024 |
December 31,
2023 |
||||||||||||||||
In millions |
Recorded
Amount |
Fair
Value |
Recorded
Amount |
Fair
Value |
|||||||||||||
Variable rate debt | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||
Fixed rate debt |
|
|
|
|
|||||||||||||
Total debt | $ |
|
$ |
|
$ |
|
$ |
|
September 30, 2024 | |||||||||||||||||
In millions | Level 1 | Level 2 | Level 3 | NAV | Total | ||||||||||||
Recurring fair value measurements | |||||||||||||||||
Interest rate contract liabilities
|
$ |
|
$ |
(
|
$ |
|
$ |
|
$ |
(
|
|||||||
Foreign currency contract liabilities |
|
(
|
|
|
(
|
||||||||||||
Deferred compensation plan assets |
|
|
|
|
|
||||||||||||
Total recurring fair value measurements | $ |
|
$ |
(
|
$ |
|
$ |
|
$ |
(
|
|||||||
December 31, 2023 | |||||||||||||||||
In millions | Level 1 | Level 2 | Level 3 | NAV | Total | ||||||||||||
Recurring fair value measurements | |||||||||||||||||
Interest rate contract assets | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||
Foreign currency contract assets |
|
|
|
|
|
||||||||||||
Foreign currency contract liabilities |
|
(
|
|
|
(
|
||||||||||||
Deferred compensation plan assets |
|
|
|
|
|
||||||||||||
Total recurring fair value measurements | $ |
|
$ |
(
|
$ |
|
$ |
|
$ |
(
|
|||||||
Three months ended | Nine months ended | ||||||||||||||||
In millions |
September 30,
2024 |
September 30,
2023 |
September 30,
2024 |
September 30,
2023 |
|||||||||||||
Service cost | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||
Interest cost |
|
|
|
|
|||||||||||||
Expected return on plan assets |
(
|
(
|
(
|
(
|
|||||||||||||
Net periodic benefit expense | $ |
|
$ |
|
$ |
|
$ |
|
Three months ended | Nine months ended | ||||||||||||||||
In millions |
September 30,
2024 |
September 30,
2023 |
September 30,
2024 |
September 30,
2023 |
|||||||||||||
Flow | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||
Water Solutions |
|
|
|
|
|||||||||||||
Pool |
|
|
|
|
|||||||||||||
Reportable segment net sales
|
|
|
|
|
|||||||||||||
Corporate and other
|
|
|
|
|
|||||||||||||
Net sales
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||
Three months ended | Nine months ended | ||||||||||||||||
In millions |
September 30,
2024 |
September 30,
2023 |
September 30,
2024 |
September 30,
2023 |
|||||||||||||
Reportable segment income
|
|||||||||||||||||
Flow
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||
Water Solutions
|
|
|
|
|
|||||||||||||
Pool
|
|
|
|
|
|||||||||||||
Reportable segment income
|
|
|
|
|
|||||||||||||
Corporate and other
|
(
|
(
|
(
|
(
|
|||||||||||||
Asset impairment and write-offs |
(
|
(
|
(
|
(
|
|||||||||||||
Restructuring and other |
(
|
(
|
(
|
(
|
|||||||||||||
Transformation costs |
(
|
(
|
(
|
(
|
|||||||||||||
Intangible amortization |
(
|
(
|
(
|
(
|
|||||||||||||
Legal accrual adjustments and settlements |
(
|
|
|
(
|
|||||||||||||
Interest expense, net |
(
|
(
|
(
|
(
|
|||||||||||||
Other (expense) income
|
(
|
(
|
(
|
|
|||||||||||||
Income from continuing operations before income taxes | $ |
|
$ |
|
$ |
|
$ |
|
In millions |
September 30,
2024 |
||||
Beginning balance | $ |
|
|||
Service and product warranty provision |
|
||||
Payments |
(
|
||||
Foreign currency translation |
|
||||
Ending balance | $ |
|
Three months ended | ||||||||||||||
In millions |
September 30,
2024 |
September 30,
2023 |
$
Change |
% / Point
Change |
||||||||||
Net sales | $ | 993.4 | $ | 1,008.8 | $ | (15.4) | (1.5) | % | ||||||
Cost of goods sold | 600.2 | 637.0 | (36.8) | (5.8) | % | |||||||||
Gross profit | 393.2 | 371.8 | 21.4 | 5.8 | % | |||||||||
% of net sales
|
39.6 | % | 36.9 | % | 2.7 | pts | ||||||||
Selling, general and administrative
|
190.4 | 166.2 | 24.2 | 14.6 | % | |||||||||
% of net sales
|
19.2 | % | 16.5 | % | 2.7 | pts | ||||||||
Research and development
|
22.9 | 25.5 | (2.6) | (10.2) | % | |||||||||
% of net sales | 2.3 | % | 2.5 | % | (0.2) | pts | ||||||||
Operating income | 179.9 | 180.1 | (0.2) | (0.1) | % | |||||||||
% of net sales | 18.1 | % | 17.9 | % | 0.2 | pts | ||||||||
Other income
|
(0.1) | (0.3) | 0.2 | N.M. | ||||||||||
Net interest expense | 19.8 | 27.5 | (7.7) | (28.0) | % | |||||||||
Income from continuing operations before income taxes | 160.2 | 152.9 | 7.3 | 4.8 | % | |||||||||
Provision for income taxes
|
20.6 | 20.8 | (0.2) | (1.0) | % | |||||||||
Effective tax rate | 12.9 | % | 13.6 | % | (0.7) | pts |
Nine months ended | ||||||||||||||
In millions |
September 30,
2024 |
September 30,
2023 |
$
Change |
% / Point
Change |
||||||||||
Net sales | $ | 3,109.9 | $ | 3,119.9 | $ | (10.0) | (0.3) | % | ||||||
Cost of goods sold | 1,888.7 | 1,966.8 | (78.1) | (4.0) | % | |||||||||
Gross profit | 1,221.2 | 1,153.1 | 68.1 | 5.9 | % | |||||||||
% of net sales
|
39.3 | % | 37.0 | % | 2.3 | pts | ||||||||
Selling, general and administrative expenses
|
540.7 | 504.6 | 36.1 | 7.2 | % | |||||||||
% of net sales
|
17.4 | % | 16.2 | % | 1.2 | pts | ||||||||
Research and development expenses
|
71.8 | 76.3 | (4.5) | (5.9) | % | |||||||||
% of net sales | 2.3 | % | 2.4 | % | (0.1) | pts | ||||||||
Operating income | 608.7 | 572.2 | 36.5 | 6.4 | % | |||||||||
% of net sales | 19.6 | % | 18.3 | % | 1.3 | pts | ||||||||
Other expense (income) | 0.8 | (4.4) | 5.2 | N.M. | ||||||||||
Net interest expense | 73.4 | 91.7 | (18.3) | (20.0) | % | |||||||||
Income from continuing operations before income taxes | 534.5 | 484.9 | 49.6 | 10.2 | % | |||||||||
Provision for income taxes
|
75.3 | 70.1 | 5.2 | 7.4 | % | |||||||||
Effective tax rate | 14.1 | % | 14.5 | % | (0.4) | pts |
Three months ended September 30, 2024 | Nine months ended September 30, 2024 | |||||||
over the prior year period | over the prior year period | |||||||
Volume | (3.7) | % | (2.1) | % | ||||
Price | 2.2 | 2.0 | ||||||
Core growth | (1.5) | (0.1) | ||||||
Acquisition/Divestitures | (0.2) | (0.1) | ||||||
Currency | 0.2 | (0.1) | ||||||
Total | (1.5) | % | (0.3) | % |
Three months ended | Nine months ended | ||||||||||||||||||||||||||||
In millions |
September 30,
2024 |
September 30,
2023 |
% / Point Change |
September 30,
2024 |
September 30,
2023 |
% / Point Change | |||||||||||||||||||||||
Net sales | $ | 372.2 | $ | 400.2 | (7.0)% | $ | 1,153.3 | $ | 1,203.6 | (4.2)% | |||||||||||||||||||
Segment income
|
82.8 | 77.5 | 6.8% | 244.5 | 217.3 | 12.5% | |||||||||||||||||||||||
% of net sales | 22.2 | % | 19.4 | % | 2.8 | pts | 21.2 | % | 18.1 | % | 3.1 | pts |
Three months ended September 30, 2024 | Nine months ended September 30, 2024 | |||||||
over the prior year period | over the prior year period | |||||||
Volume | (9.1) | % | (5.9) | % | ||||
Price | 1.8 | 1.7 | ||||||
Core growth | (7.3) | (4.2) | ||||||
Currency | 0.3 | — | ||||||
Total | (7.0) | % | (4.2) | % |
Three months ended September 30, 2024 | Nine months ended September 30, 2024 | |||||||
over the prior year period | over the prior year period | |||||||
Growth/Price | 3.5 | pts | 2.5 | pts | ||||
Inflation | (2.0) | (2.2) | ||||||
Productivity | 1.3 | 2.8 | ||||||
Total | 2.8 | pts | 3.1 | pts |
Three months ended | Nine months ended | ||||||||||||||||||||||||||||
In millions |
September 30,
2024 |
September 30,
2023 |
% / Point Change |
September 30,
2024 |
September 30,
2023 |
% / Point Change | |||||||||||||||||||||||
Net sales | $ | 289.5 | $ | 299.4 | (3.3)% | $ | 873.1 | $ | 907.6 | (3.8)% | |||||||||||||||||||
Segment income | 64.4 | 68.8 | (6.4)% | 192.9 | 196.0 | (1.6)% | |||||||||||||||||||||||
% of net sales | 22.2 | % | 23.0 | % | (0.8) | pts | 22.1 | % | 21.6 | % | 0.5 | pts |
Three months ended September 30, 2024 | Nine months ended September 30, 2024 | |||||||
over the prior year period | over the prior year period | |||||||
Volume | (4.6) | % | (4.8) | % | ||||
Price | 1.1 | 1.3 | ||||||
Core growth | (3.5) | (3.5) | ||||||
Currency | 0.2 | (0.3) | ||||||
Total | (3.3) | % | (3.8) | % |
Three months ended September 30, 2024 | Nine months ended September 30, 2024 | |||||||
over the prior year period | over the prior year period | |||||||
Growth/Price
|
— | pts | 1.3 | pts | ||||
Currency | 0.5 | — | ||||||
Inflation | (2.2) | (2.3) | ||||||
Productivity | 0.9 | 1.5 | ||||||
Total | (0.8) | pts | 0.5 | pts |
Three months ended | Nine months ended | ||||||||||||||||||||||||||||
In millions |
September 30,
2024 |
September 30,
2023 |
% / Point Change |
September 30,
2024 |
September 30,
2023 |
% / Point Change | |||||||||||||||||||||||
Net sales | $ | 331.4 | $ | 308.8 | 7.3% | $ | 1,082.4 | $ | 1,007.4 | 7.4% | |||||||||||||||||||
Segment income | 112.7 | 90.6 | 24.4% | 357.1 | 311.9 | 14.5% | |||||||||||||||||||||||
% of net sales | 34.0 | % | 29.3 | % | 4.7 | pts | 33.0 | % | 31.0 | % | 2.0 | pts |
Three months ended September 30, 2024 | Nine months ended September 30, 2024 | |||||||
over the prior year period | over the prior year period | |||||||
Volume | 4.1 | % | 4.9 | % | ||||
Price | 3.9 | 3.0 | ||||||
Core growth | 8.0 | 7.9 | ||||||
Acquisition/Divestiture
|
(0.7) | (0.5) | ||||||
Total | 7.3 | % | 7.4 | % |
Three months ended September 30, 2024 | Nine months ended September 30, 2024 | |||||||
over the prior year period | over the prior year period | |||||||
Growth/Price/Divestiture
|
1.0 | pts | 1.9 | pts | ||||
Inflation | (1.5) | (1.8) | ||||||
Productivity | 5.2 | 1.9 | ||||||
Total | 4.7 | pts | 2.0 | pts |
In millions |
September 30,
2024 |
December 31,
2023 |
$ Change | % Change | ||||||||||
Flow | $ | 344.7 | $ | 390.1 | $ | (45.4) | (11.6) | % | ||||||
Water Solutions | 84.3 | 108.5 | (24.2) | (22.3) | % | |||||||||
Pool | 94.6 | 239.7 | (145.1) | (60.5) | % | |||||||||
Total backlog
|
$ | 523.6 | $ | 738.3 | $ | (214.7) | (29.1) | % |
Nine months ended | ||||||||
In millions |
September 30,
2024 |
September 30,
2023 |
||||||
Net cash provided by (used for): | ||||||||
Operating activities of continuing operations | $ | 680.4 | $ | 502.3 | ||||
Investing activities | (68.2) | (45.9) | ||||||
Financing activities | (560.0) | (426.2) |
Nine months ended | |||||||||||||||||
In millions |
September 30,
2024 |
September 30,
2023 |
|||||||||||||||
Net cash provided by operating activities of continuing operations
|
$ | 680.4 | $ | 502.3 | |||||||||||||
Capital expenditures of continuing operations | (51.7) | (54.8) | |||||||||||||||
Proceeds from sale of property and equipment of continuing operations | 0.4 | 5.4 | |||||||||||||||
Free cash flow from continuing operations | 629.1 | 452.9 | |||||||||||||||
Net cash used for operating activities of discontinued operations | (0.2) | (1.6) | |||||||||||||||
Free cash flow | $ | 628.9 | $ | 451.3 |
In millions |
September 30,
2024 |
December 31,
2023 |
||||||
Current assets
(1)
|
$ | 102.1 | $ | 71.7 | ||||
Noncurrent assets
(2)
|
2,576.1 | 2,686.9 | ||||||
Current liabilities
(3)
|
1,911.7 | 1,659.0 | ||||||
Noncurrent liabilities
(4)
|
1,861.3 | 2,331.4 | ||||||
(1)
No assets due from non-guarantor subsidiaries were included as of September 30, 2024 and December 31, 2023, respectively.
|
||||||||
(2)
Includes assets due from non-guarantor subsidiaries of $2,562.6 million and
$2,673.3 million
as of September 30, 2024 and December 31, 2023, respectively.
|
||||||||
(3)
Includes liabilities due to non-guarantor subsidiaries of $1,858.3 million and
$1,583.6 million
as of September 30, 2024 and December 31, 2023, respectively.
|
||||||||
(4)
Includes liabilities due to non-guarantor subsidiaries of $162.7 million and
$268.4 million
as of September 30, 2024 and December 31, 2023, respectively.
|
(a) | (b) | (c) | (d) | ||||||||||||||
Period |
Total number
of shares purchased |
Average price
paid per share |
Total number of
shares purchased as
part of publicly
announced plans or
programs
|
Dollar value of
shares that may yet
be purchased under
the plans or
programs
|
|||||||||||||
July 1 - July 27
|
168 | $ | 74.42 | — | $ | 550,002,247 | |||||||||||
July 28 - August 24
|
14,109 | 87.85 | — | 550,002,247 | |||||||||||||
August 25 - September 30
|
553,180 | 90.85 | 550,226 | 500,002,264 | |||||||||||||
Total | 567,457 | 550,226 |
(a)
|
(b)
|
||||||||||||||||
Name and Title
|
Action Taken
|
Date
|
Type of Trading Arrangement
|
Duration of Trading Arrangement
|
Aggregate Number of Shares to be Sold
|
||||||||||||
|
|
|
|
02/28/2025 |
Up to
|
List of Guarantors and Subsidiary Issuers of Guaranteed Securities. (Incorporated by reference to Exhibit 22 to the Quarterly Report on Form 10-Q of Pentair plc for the quarter ended September 30, 2022 (File No. 001-11625)). | ||||||||
Certification of Chief Executive Officer. | ||||||||
Certification of Chief Financial Officer. | ||||||||
Certification of Chief Executive Officer, Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. | ||||||||
Certification of Chief Financial Officer, Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. | ||||||||
101 |
The following materials from Pentair plc’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2024 are filed herewith, formatted in iXBRL (Inline Extensible Business Reporting Language): (i) the Condensed Consolidated Statements of Operations and Comprehensive Income for the three and nine months ended September 30, 2024 and 2023, (ii) the Condensed Consolidated Balance Sheets as of September 30, 2024 and December 31, 2023, (iii) the Condensed Consolidated Statements of Cash Flows for the nine months ended September 30, 2024 and 2023, (iv) the Condensed Consolidated Statements of Changes in Equity for the three and nine months ended September 30, 2024 and 2023, (v) Notes to Condensed Consolidated Financial Statements, and (vi) the information included in Part II, Item 5(c). The instance document does not appear in the interactive data file because its XBRL tags are embedded within the Inline XBRL document.
|
|||||||
104 | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101). |
Pentair plc | ||||||||
Registrant | ||||||||
By | /s/ Robert P. Fishman | |||||||
Robert P. Fishman | ||||||||
Executive Vice President, Chief Financial Officer and Chief Accounting Officer | ||||||||
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
---|
DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
---|
No information found
No Customers Found
Price
Yield
Owner | Position | Direct Shares | Indirect Shares |
---|